Literature DB >> 28092635

Evaluating the accuracy of a three-term pencil beam algorithm in heterogeneous media.

J W Chapman1, N C Knutson, J D Fontenot, W D Newhauser, K R Hogstrom.   

Abstract

The goal of this work was to evaluate the accuracy of our in-house analytical dose calculation code against MCNPX data in heterogeneous phantoms. The analytical model utilizes a pencil beam model based on Fermi-Eyges theory to account for multiple Coulomb scattering and a least-squares fit to Monte Carlo data to account for nonelastic nuclear interactions as well as any remaining, uncharacterized scatter (the 'nuclear halo'). The model characterized dose accurately (up to 1% of maximum dose in broad fields (4  ×  4 cm2 and 10  ×  10 cm2) and up to 0.01% in a narrow field (0.1  ×  0.1 cm2) fit to MCNPX data). The accuracy of the model was benchmarked in three types of stylized phantoms: (1) homogeneous, (2) laterally infinite slab heterogeneities, and (3) laterally finite slab heterogeneities. Results from homogeneous phantoms and laterally infinite slab heterogeneities showed high levels of accuracy (>98% of points within 2% or 0.1 cm distance-to-agreement (DTA)). However, because range straggling and secondary particle production were not included in our model, central-axis dose differences of 2-4% were observed in laterally infinite slab heterogeneities when compared to Monte Carlo dose. In the presence of laterally finite slab heterogeneities, the analytical model resulted in lower pass rates (>96% of points within 2% or 0.1 cm DTA), which was attributed to the use of the central-axis approximation.

Entities:  

Mesh:

Year:  2017        PMID: 28092635     DOI: 10.1088/1361-6560/aa51aa

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  1 in total

Review 1.  Treatment planning for proton therapy: what is needed in the next 10 years?

Authors:  Hakan Nystrom; Maria Fuglsang Jensen; Petra Witt Nystrom
Journal:  Br J Radiol       Date:  2019-08-07       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.